采用来自HLA不相合供者的骨髓移植治疗白血病。HLA差异对移植物抗宿主病、复发及生存的影响。 - Suppr | 超能文献

Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival.

作者信息

Hansen J A, Anasetti C, Beatty P G, Martin P J, Sanders J E, Storb R, Thomas E D

机构信息

Fred Hutchinson Cancer Research Center, Seattle, WA.

出版信息

Bone Marrow Transplant. 1990 Jul;6 Suppl 1:108-11.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Treatment of leukemia by marrow transplantation from HLA incompatible donors. Effect of HLA-disparity on GVHD, relapse and survival.采用来自HLA不相合供者的骨髓移植治疗白血病。HLA差异对移植物抗宿主病、复发及生存的影响。

Bone Marrow Transplant. 1990 Jul;6 Suppl 1:108-11.

2

Bone marrow transplantation and graft-versus-host disease.骨髓移植与移植物抗宿主病

Curr Opin Immunol. 1989;2(6):870-5.

3

Bone marrow transplantation from donors other than HLA identical siblings. What have we learned from previous experiences?来自 HLA 同型同胞以外供者的骨髓移植。我们从以往的经验中学到了什么？

Bone Marrow Transplant. 1990 Jul;6 Suppl 1:112-4.

4

CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.来自基因分型 HLA 不相同的相关供体的 CD6+ T 细胞耗竭的异基因骨髓移植。

Biol Blood Marrow Transplant. 1997 Apr;3(1):11-7.

5

Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation.供体来源的宿主反应性细胞毒性和辅助性T细胞与替代供体T细胞去除的骨髓移植后结局的关联

Bone Marrow Transplant. 1997 May;19(10):1001-9. doi: 10.1038/sj.bmt.1700779.

6

Graft-versus-host disease: effects on long term disease free survival in marrow transplantation for haematological malignancies.移植物抗宿主病：对血液系统恶性肿瘤骨髓移植长期无病生存的影响

Bone Marrow Transplant. 1989 Dec;4 Suppl 4:153-5.

7

Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.异基因反应性以及抗受体特异性产生白细胞介素2的辅助性T淋巴细胞前体细胞频率对骨髓移植后异基因反应性的预测价值。

Dan Med Bull. 2002 May;49(2):89-108.

8

Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.白血病骨髓移植受者移植物抗宿主病的个体化预防

Bone Marrow Transplant. 1994 Jul;14(1):79-87.

9

Omission of day 11 methotrexate does not appear to influence the incidence of moderate to severe acute graft-versus-host disease, chronic graft-versus-host disease, relapse rate or survival after HLA-identical sibling bone marrow transplantation.在 HLA 全相合同胞骨髓移植后，省略第 11 天的甲氨蝶呤似乎不会影响中重度急性移植物抗宿主病、慢性移植物抗宿主病的发生率、复发率或生存率。

Bone Marrow Transplant. 1995 Dec;16(6):755-8.

10

Immunobiology of bone marrow transplantation as treatment for hematologic malignancies.

Transplant Proc. 1991 Aug;23(4):2123-7.

引用本文的文献

1

Is there a stronger graft-versus-leukemia effect using HLA-haploidentical donors compared with HLA-identical siblings?使用与 HLA 完全相同的供体相比，HLA 单倍体相合供体是否具有更强的移植物抗白血病效应？

Leukemia. 2016 Feb;30(2):447-55. doi: 10.1038/leu.2015.232. Epub 2015 Aug 21.

2

Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.因T淋巴细胞识别单一HLA - DPB1*0501错配导致的急性移植物抗宿主病

J Clin Invest. 1996 Jul 1;98(1):100-7. doi: 10.1172/JCI118753.